91
Growth Score
pts
Heat Score
81 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
351853
SynSilico is an AI-driven drug discovery company that leverages computational chemistry and machine learning to accelerate molecule design.
- Victor Plesciuc: Director of Data Science and AI
- Daniel Mink: CEO
About the Company
SynSilico is a biotechnology company that develops AI-powered solutions for drug discovery, utilizing computational chemistry and machine learning to enhance molecule design. Formed as a joint venture between Genzai and InnoSyn, the company leverages advanced in silico technologies to support pharmaceutical and biotechnology organizations in
identifying promising compounds, reducing development timelines, and improving research efficiency. SynSilico focuses on data-driven innovation to enhance decision-making throughout the early stages of drug discovery and development.
